Department of Cardiac Surgery, Cardiovascular Center, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany; PhD Program in Angio-Cardio-Thoracic Pathophysiology and Imaging, Sapienza University of Rome, Rome, Italy.
Cardiac Surgery Department, University of Münster, Münster, Germany.
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1406-1415.e3. doi: 10.1016/j.jtcvs.2018.08.085. Epub 2018 Sep 27.
To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method.
We retrospectively analyzed preoperative contrast-enhanced multidetector computed tomography scans of patients who underwent transcatheter aortic valve implantation in our center between 2009 and 2016. Calcium volume was calculated for each aortic cusp in the aortic valve, left ventricular outflow tract, and device landing zone.
Overall, 539 patients were included in the study who had experience with 4 prothesis types (SapienXT [Edwards Lifesciences, Irvine, Calif] [n = 192], Sapien3 [Edwards Lifesciences] [n = 206], CoreValve EvolutR [Medtronic, Minneapolis, Minn] [n = 44], and Acurate [Symetis, Ecublens, Switzerland] [n = 97]). Median calcium volume in the device landing zone was 757 mm, with no significant differences among the 4 prosthesis groups. None of the patients had severe PVL. The overall incidence of mild-to-moderate PVL was 15.8% (95% confidence interval [CI], 12.8%-19.1%). On multivariate logistic regression, device landing zone calcification (P = .00006; odds ratio for an increase of 100 mm, 1.08; 95% CI, 1.04-1.13) and use of the CoreValve (P = .0028; odds ratio, 4.1; 95% CI, 1.6-10 with SapienXT as reference) prosthesis were found to be associated with mild or greater PVL. In contrast, degree of oversizing (P = .002; odds ratio, 0.97; 95% CI, 0.95-0.99), and use of Sapien3 (P = .00005; odds ratio, 0.23; 95% CI, 0.11-0.47 with SapienXT as reference) were associated with a lower incidence of mild or greater PVL.
Aortic calcification volume in the device landing zone is associated with residual PVL after transcatheter aortic valve implantation. When taking calcification into account, the balloon-expandable prosthesis Sapien3 seems to be associated with a lower incidence of PVL.
在一个大型单中心队列中,评估经导管主动脉瓣置换术后瓣周漏(PVL)的危险因素,包括使用可重复的方法测量主动脉瓣钙化。
我们回顾性分析了 2009 年至 2016 年期间在我们中心接受经导管主动脉瓣置换术的患者的术前对比增强多排螺旋 CT 扫描。计算每个主动脉瓣叶、左心室流出道和器械着陆区的主动脉瓣钙化体积。
共有 539 例患者纳入本研究,他们经历了 4 种假体类型(SapienXT [爱德华兹生命科学公司,欧文,加利福尼亚州] [n=192]、Sapien3 [爱德华兹生命科学公司] [n=206]、CoreValve EvolutR [美敦力,明尼苏达州明尼阿波利斯] [n=44]和 Acurate [Symetis,埃库布伦,瑞士] [n=97])。器械着陆区的钙体积中位数为 757mm,4 个假体组之间无显著差异。所有患者均无严重的 PVL。轻度至中度 PVL 的总体发生率为 15.8%(95%置信区间[CI],12.8%-19.1%)。多变量逻辑回归显示,器械着陆区钙化(P=0.00006;每增加 100mm 的优势比为 1.08;95%CI,1.04-1.13)和使用 CoreValve(P=0.0028;优势比为 4.1;95%CI,1.6-10,以 SapienXT 为参考)假体与轻度或更严重的 PVL 相关。相比之下,过度扩张程度(P=0.002;优势比,0.97;95%CI,0.95-0.99)和使用 Sapien3(P=0.00005;优势比,0.23;95%CI,0.11-0.47,以 SapienXT 为参考)与轻度或更严重的 PVL 发生率较低相关。
器械着陆区的主动脉钙化体积与经导管主动脉瓣置换术后残余 PVL 相关。在考虑钙化的情况下,球囊扩张型假体 Sapien3 似乎与较低的 PVL 发生率相关。